Campylobacteriosis in Dogs: Symptoms, Diagnosis, Treatment, and Zoonotic Risk Guide
This article is reviewed for clinical accuracy. Always consult your veterinarian for diagnosis and treatment.
Key Takeaways
- Campylobacteriosis in dogs is caused primarily by Campylobacter jejuni, with Campylobacter coli and Campylobacter upsaliensis as secondary species; all three are curved, comma-shaped (“gull-wing”), gram-negative, microaerophilic rods in the family Campylobacteraceae; the microaerophilic growth requirement (5 percent oxygen, 10 percent carbon dioxide atmosphere) is a defining diagnostic characteristic: these bacteria cannot grow in standard aerobic or anaerobic culture conditions and require specialized incubators and selective culture media (Campy-BAP or CCDA agar) at 42 degrees Celsius rather than 37 degrees Celsius; the higher incubation temperature is specifically selective for C. jejuni and C. coli (thermophilic campylobacters), and failure to use 42 degrees Celsius will produce false-negative cultures even when the organism is present in the sample; veterinary laboratories that do not perform routine Campylobacter cultures or that incubate at 37 degrees Celsius will miss the diagnosis, which is why PCR from feces is increasingly preferred for its sensitivity and because it does not depend on the bacteria surviving transport and culture conditions.
- Campylobacter jejuni is the leading bacterial cause of foodborne gastroenteritis in humans in the United States, responsible for an estimated 1.5 million cases annually according to the CDC; dogs are a recognized reservoir and transmission source, particularly raw-fed dogs, shelter dogs with high colonization prevalence (studies report 20 to 50 percent fecal shedding rates in shelter populations), recently acquired puppies from pet stores or mass breeders, and dogs from households where raw poultry is handled; the zoonotic significance is highest in households with young children under age 5, elderly individuals, pregnant people, and immunocompromised individuals (chemotherapy patients, people with HIV, organ transplant recipients on immunosuppressive therapy); in these households, a dog with acute campylobacteriosis represents a genuine household infection risk and the family’s healthcare provider should be notified; strict handwashing after handling the dog, its feces, bedding, or food bowls is essential during the infectious period.
- Many dogs carrying Campylobacter jejuni are entirely asymptomatic shedders with no clinical signs; the transition from asymptomatic carrier to clinically ill dog is associated with several host factors: age under 6 months (puppies are the highest-risk group for clinical disease), concurrent illness or parasitism that disrupts the intestinal barrier (canine parvovirus, giardiasis, cryptosporidiosis, hookworms), stress from rehoming, transport, or shelter housing, immunosuppressive therapy or underlying immunodeficiency, and malnutrition; in adult healthy dogs from stable single-dog households, a positive Campylobacter PCR or culture is often found incidentally and does not necessarily warrant treatment; the decision to treat should be based on clinical signs, not test results alone, with the exception of immunocompromised household members who raise the treatment threshold.
- Clinical campylobacteriosis in dogs produces mucoid to watery diarrhea, often with visible fresh blood or blood streaking the stool surface, accompanied by tenesmus (straining), increased frequency of defecation, and occasionally bile-stained watery feces; vomiting is present in approximately 25 percent of clinical cases; systemic signs (fever, lethargy, anorexia) occur more commonly in puppies and in dogs with severe or extraintestinal disease; the diarrhea is typically self-limiting within 5 to 7 days in healthy adult dogs without antibiotic treatment; however, in puppies under 12 weeks, dogs with concurrent parvovirus or other pathogens, and immunocompromised dogs, the illness can be prolonged and severe; importantly, Campylobacter is frequently identified alongside other enteric pathogens (parvovirus, Giardia, Clostridium, Cryptosporidium, Salmonella) and co-infections complicate both prognosis and treatment decisions.
- Antibiotic treatment for clinical campylobacteriosis should follow a strict first-line macrolide approach: azithromycin 5 mg/kg orally once daily for 3 to 5 days or erythromycin 10 to 15 mg/kg orally twice daily for 5 to 7 days; macrolides are the recommended first-line agents because fluoroquinolone resistance in C. jejuni has risen dramatically due to heavy fluoroquinolone use in the poultry industry (enrofloxacin and ciprofloxacin resistance rates of 20 to 50 percent or higher in some populations); using enrofloxacin empirically for Campylobacter in dogs risks treatment failure and additionally contributes to the broader antimicrobial resistance problem; if a C. jejuni isolate has documented susceptibility to enrofloxacin on culture and sensitivity testing, it remains a reasonable option, but empirical treatment should default to azithromycin; importantly, antibiotic treatment does NOT reduce Campylobacter shedding duration in dogs (unlike in humans where antibiotics can shorten illness), and dogs may continue to shed the organism in their feces for weeks after clinical recovery regardless of whether they were treated.
- Raw meat diets are the most consistently identified risk factor for Campylobacter colonization and shedding in pet dogs across multiple studies; dogs fed commercial raw diets (including freeze-dried or frozen raw food) have significantly higher Campylobacter shedding prevalence than dogs fed cooked or commercially processed kibble; this is because C. jejuni colonizes the gastrointestinal tracts of poultry at very high rates (studies report 50 to 90 percent prevalence in commercial broiler chickens), and raw poultry handling by owners, raw poultry-based commercial dog foods, and raw feeding of chicken necks or organ meats are all documented transmission routes; switching from a raw diet to commercially processed food reduces but does not eliminate shedding risk; this is a concrete, modifiable risk factor that veterinarians can counsel owners about, particularly in households with vulnerable human members.
The 10-week-old Labrador Retriever mix had been home for 4 days when the diarrhea started; the new owners had been feeding a commercial raw chicken-based diet as recommended by the breeder, and by day 2 the diarrhea was profuse and mucoid with visible blood streaking; the puppy was straining frequently between bouts and had vomited twice; at the clinic, a parvovirus SNAP test was negative, fecal flotation showed no parasites, and a fecal panel by PCR returned positive for Campylobacter jejuni with a concurrent weak positive for Giardia; the puppy was started on fenbendazole for Giardia and azithromycin for Campylobacter; the owners were counseled to switch immediately to a commercial processed puppy food, to wash their hands after every contact with the dog or its feces, and to keep the puppy away from their 18-month-old child until the diarrhea resolved; the diarrhea improved substantially by day 4 and resolved by day 7; a follow-up PCR 2 weeks later was still positive for Campylobacter despite clinical resolution, illustrating the persistence of shedding after apparent recovery.
The Organism: Why Campylobacter Is Clinically Unique
| Feature | Detail |
|---|---|
| Organism name | Campylobacter jejuni (primary), C. coli, C. upsaliensis, C. lari; genus Campylobacter, family Campylobacteraceae; gram-negative curved or spiral rod; comma-shaped or “S-shaped” (“gull-wing” appearance under dark-field or phase contrast microscopy) |
| Growth requirements | Microaerophilic: 5 percent O2, 10 percent CO2; will NOT grow under standard aerobic (21 percent O2) or strict anaerobic conditions; selective media (Campy-BAP, CCDA, or Skirrow’s) required to suppress competing flora; incubation at 42 degrees Celsius (C. jejuni and C. coli are thermophilic; C. upsaliensis grows at 37 degrees Celsius but is missed on selective media at 42 degrees) |
| Biochemical ID | Oxidase-positive; catalase-positive; hippurate hydrolysis-positive (C. jejuni only; C. coli and C. upsaliensis are hippurate-negative); motility by single polar flagellum; distinctive darting corkscrew motility under dark-field microscopy; indoxyl acetate hydrolysis negative |
| Environmental stability | Fragile outside a host: survives days to a few weeks in cool, moist environments (water, wet feces, moist soil); killed by standard disinfectants (bleach, quaternary ammonium compounds), heat above 55 degrees Celsius, drying, and most cooking temperatures (71 degrees Celsius internal for poultry); does NOT survive freezing well (but freeze-dried raw commercial dog food can still harbor viable organisms if not heated) |
| Transmission routes | Fecal-oral; ingestion of contaminated raw meat (especially poultry); contaminated water; contact with infected animal feces; person-to-dog and dog-to-person transmission via hands and fomites; vertical transmission from dam to neonates; sexual or reproductive tract colonization has been reported; unpasteurized milk |
| Zoonotic significance | C. jejuni is the leading bacterial cause of foodborne gastroenteritis in the United States (CDC estimate: 1.5 million cases per year); dogs are a documented reservoir and transmission source, particularly raw-fed dogs and recently acquired puppies; risk highest in households with immunocompromised members, young children, elderly individuals, and pregnant people |
Pathogenesis
C. jejuni causes disease through several mechanisms that explain its clinical presentation:
- Adherence and invasion: C. jejuni uses its flagella for motility and to penetrate the intestinal mucus layer, then adheres to jejunal and ileal epithelial cells via specific adhesins; the bacterium is capable of intracellular invasion of enterocytes, unlike purely adherent pathogens; invasion triggers a host inflammatory response
- Toxin production: C. jejuni produces the Campylobacter cytolethal distending toxin (CDT), which causes DNA damage and blocks cell division in epithelial cells; this contributes to the mucosal damage and bloody diarrhea; a cholera-like enterotoxin has also been described that may contribute to secretory diarrhea; however, not all strains produce both toxins, contributing to the variability in clinical severity
- Inflammatory response: the host mounts a robust innate immune response with neutrophil and monocyte infiltration into the lamina propria; this inflammatory response causes the mucosal disruption, increased permeability, and hemorrhage (resulting in bloody diarrhea) that characterize clinical disease; the tenesmus reflects rectal and colonic inflammation and irritation
- Large intestine involvement: despite the organism colonizing the small intestine (primarily the jejunum and ileum), the clinical presentation often resembles large bowel diarrhea in dogs: mucoid, small-volume, frequent stools with tenesmus and fresh blood; this reflects colonic involvement in the inflammatory process
- Post-infectious sequelae: in humans, C. jejuni infection is a well-established trigger for Guillain-Barre syndrome (acute inflammatory demyelinating polyneuropathy) due to molecular mimicry between C. jejuni lipooligosaccharides and gangliosides in peripheral nerve myelin; post-infectious reactive arthritis is also described; clinical significance of these post-infectious syndromes in dogs has not been definitively established but represents an active area of investigation
Clinical Signs and Presentation
| Sign | Frequency/Description | Notes |
|---|---|---|
| Mucoid diarrhea | Most common clinical sign; diarrhea ranges from soft and mucoid to watery; may have bile staining | Present in nearly all clinically ill dogs; character varies by severity and concurrent pathogens |
| Bloody diarrhea (hematochezia) | Fresh blood coating or mixed with stool; approximately 50 to 70 percent of symptomatic dogs | More common in puppies and severe cases; the blood is typically fresh, not digested (melena), reflecting colonic rather than upper GI hemorrhage |
| Tenesmus | Straining to defecate, frequent defecation attempts, painful posturing | Common; reflects colonic and rectal inflammation; owners often mistake tenesmus for constipation |
| Vomiting | Approximately 25 percent of symptomatic cases | Usually mild and intermittent; severe or persistent vomiting should prompt evaluation for concurrent pathogens |
| Fever | More common in puppies; temperature may reach 39.5 to 40.5 degrees Celsius | Fever in adult dogs is unusual for uncomplicated campylobacteriosis and should prompt investigation for extraintestinal disease or concurrent pathogens |
| Lethargy and anorexia | More common in puppies and in severe or prolonged cases | Healthy adult dogs often remain bright and alert despite diarrhea; puppies may be noticeably depressed |
| Dehydration | Mild to moderate in most clinical cases; severe in puppies with high-volume diarrhea | Assess skin turgor, mucous membrane moisture, and capillary refill time; IV fluid therapy may be needed in puppies |
| Asymptomatic shedding | Studies report 20 to 50 percent fecal shedding prevalence in shelter dogs and 5 to 15 percent in pet dogs; most are asymptomatic | Asymptomatic carriage is the most common outcome; clinical disease represents the minority of colonized dogs |
Diagnosis
| Diagnostic Method | Sensitivity/Specificity | Practical Notes |
|---|---|---|
| Fecal PCR (qPCR or multiplex panels) | Sensitivity approximately 95 percent or higher; highly specific; differentiates species (C. jejuni vs. C. upsaliensis); detects non-viable organisms | Preferred method in most clinical settings; does not require viable bacteria (important because C. jejuni is fragile during transport); multiplex panels simultaneously test for Salmonella, Giardia, Cryptosporidium, Clostridium, parvovirus in one submission; increasingly available from reference labs at reasonable cost; a positive result identifies shedding but does not confirm active disease in asymptomatic dogs |
| Fecal culture (Campylobacter-specific) | Sensitivity 60 to 85 percent (lower because organisms may die during transport or be overgrown by competing flora); highly specific when positive | Must specifically request “Campylobacter culture” from the laboratory; requires Campy-BAP or CCDA selective media, microaerophilic conditions (GasPak or dedicated incubator), and 42 degrees Celsius incubation; standard fecal culture without these conditions will NOT detect Campylobacter; advantage over PCR is that isolate can be submitted for antimicrobial susceptibility testing |
| Dark-field or phase contrast microscopy of fresh feces | Sensitivity approximately 60 to 75 percent when performed within 2 hours of collection; decreases with storage time | Rapid in-clinic test; C. jejuni shows characteristic “darting” corkscrew motility; a comma-shaped or “S-shaped” motile curved rod in fresh fecal smear is strongly suggestive; limited by observer experience and must be performed very promptly on fresh unfixed samples; not sufficient for definitive diagnosis but useful for rapid preliminary assessment |
| Gram stain of fecal smear | Low sensitivity as a standalone test; characteristic morphology (curved or S-shaped pink gram-negative rods) when visualized | Not routinely used for Campylobacter diagnosis but can support suspicion when comma-shaped gram-negative rods are seen; must be differentiated from Helicobacter and other curved gram-negative organisms |
| Antimicrobial susceptibility testing | N/A (in vitro testing) | Performed on culture isolates (requires positive culture first); tests azithromycin, erythromycin, tetracycline, enrofloxacin, ciprofloxacin, ampicillin, chloramphenicol; essential to detect fluoroquinolone resistance before using enrofloxacin; if culture and sensitivity testing is not performed, empirical treatment with azithromycin is recommended rather than assuming fluoroquinolone susceptibility |
Treatment
| Treatment | Indication and Protocol |
|---|---|
| Azithromycin (first-line antibiotic) | 5 mg/kg orally once daily for 3 to 5 days; macrolide antibiotic with excellent activity against C. jejuni including fluoroquinolone-resistant strains; first-line empirical choice because fluoroquinolone resistance is widespread; generally well tolerated; minor GI side effects possible; can be used in puppies with appropriate weight-based dosing; does NOT reduce fecal shedding duration in most studies but shortens the clinical illness |
| Erythromycin (alternative macrolide) | 10 to 15 mg/kg orally twice daily for 5 to 7 days; first macrolide documented effective against Campylobacter; more GI side effects (nausea, vomiting, cramping) than azithromycin; erythromycin stimulates motilin receptors and can worsen nausea; azithromycin is generally preferred; erythromycin is an option when azithromycin is unavailable or cost-prohibitive |
| Enrofloxacin (fluoroquinolone: use only with documented susceptibility) | 5 to 10 mg/kg orally once daily; active against susceptible C. jejuni strains; however, fluoroquinolone resistance in C. jejuni has increased dramatically (resistance rates of 20 to 50 percent or higher in some regions due to routine fluoroquinolone use in commercial poultry production); do NOT use empirically without culture and sensitivity confirmation; if susceptibility is confirmed, it is a reasonable option; avoid in puppies under 12 months (risk of cartilage damage in rapidly growing dogs) |
| Supportive care: fluid therapy | IV crystalloid fluid therapy (lactated Ringer’s or Plasmalyte) for puppies and adults with moderate to severe dehydration; oral electrolyte supplementation for mild dehydration; the goal is to maintain hydration and electrolyte balance while the diarrhea resolves; rehydration is the most important intervention in young puppies with severe watery diarrhea |
| Supportive care: diet management | Bland, easily digestible diet during acute illness (boiled chicken and rice, or a commercial gastrointestinal prescription diet); avoid raw meat entirely during and after the illness; gradual transition back to regular diet as diarrhea resolves; small, frequent meals to reduce gastric burden; probiotics (Purina Fortiflora, Nutramax Proviable) to support mucosal recovery; prebiotics such as slippery elm or psyllium husk may help firm stool |
| Antiparasitic treatment if co-infection present | Fenbendazole 50 mg/kg once daily for 3 to 5 days for concurrent Giardia; pyrantel pamoate or milbemycin for hookworms; treat all identified co-pathogens; Giardia and hookworms are the most commonly co-identified parasites in puppies with clinical campylobacteriosis |
| No treatment for asymptomatic shedders (generally) | Asymptomatic dogs with positive Campylobacter testing but no diarrhea or clinical signs should generally NOT be treated with antibiotics; antibiotic treatment of asymptomatic carriers does not reliably eliminate shedding and contributes to resistance selection; exceptions include households with high-risk immunocompromised human members or other compelling clinical reasons, in which case consultation with a veterinary internist or infectious disease specialist is appropriate |
Zoonotic Precautions and Household Management
The zoonotic significance of canine campylobacteriosis requires specific owner guidance:
- Hand hygiene: thorough handwashing with soap and water for at least 20 seconds after handling the dog, picking up feces, cleaning food bowls or litter boxes, or touching bedding is the single most important protective measure; hand sanitizer is less effective than soap and water for enteric pathogens
- High-risk household members: pregnant individuals, immunocompromised individuals (chemotherapy, HIV, organ transplant recipients), elderly individuals over 65, and children under age 5 face higher risk of serious illness from C. jejuni; in these households, the ill dog should ideally be cared for by a lower-risk family member; contact between the dog and high-risk individuals should be minimized until the dog’s diarrhea resolves
- Raw feeding cessation: raw-fed dogs with confirmed campylobacteriosis should be switched to commercially processed food; if the owner insists on continuing raw feeding after recovery, they must understand the ongoing shedding risk and that switching to processed food significantly reduces (though does not eliminate) colonization risk; handle any raw meat for dogs with the same precautions as raw meat for human consumption (separate cutting boards, separate utensils, thorough handwashing, no contact with other surfaces)
- Environmental decontamination: clean contaminated areas with bleach solution (1:32 dilution, 10-minute contact time) or other effective disinfectants; C. jejuni is fragile in the environment and is killed by routine disinfectants; wash bedding in hot water with detergent; pick up and dispose of feces promptly; bag and seal fecal waste during the illness period
- Notification of healthcare provider: when a dog in a household with immunocompromised, elderly, pregnant, or pediatric members is diagnosed with campylobacteriosis, informing the family’s healthcare provider is appropriate; the healthcare provider may wish to advise additional precautions or monitor household members for diarrheal illness
Age-Specific Considerations
Puppies (Under 6 Months)
- Puppies are the demographic most likely to develop clinical campylobacteriosis rather than remaining asymptomatic carriers; the immature intestinal immune system, lack of prior exposure and acquired immunity, and higher likelihood of concurrent infections (roundworms, hookworms, Giardia, parvovirus) all contribute to clinical vulnerability; newly acquired puppies from shelters, pet stores, or breeders who feed raw meat diets are at the highest risk of presenting with acute bloody mucoid diarrhea in the first 1 to 4 weeks after acquisition; the transition stress of rehoming itself can trigger clinical disease in a puppy that was an asymptomatic shelter shedder
- In puppies under 12 weeks, campylobacteriosis can produce severe, life-threatening dehydration if high-volume watery diarrhea persists for more than 24 to 48 hours; rapid fluid loss in a small body with limited glycogen reserves leads to hypoglycemia, hypotension, and circulatory collapse if left untreated; IV fluids and hospitalization may be needed for very young severely affected puppies; the decision to hospitalize versus treat as outpatient should be based on degree of dehydration, presence of vomiting (limiting oral fluid replacement), and ability of owners to administer care at home
- Fluoroquinolones (enrofloxacin) are generally avoided in puppies under 12 months due to the risk of arthropathy (cartilage damage in rapidly growing joints); azithromycin is the preferred antibiotic for clinical campylobacteriosis in puppies; for puppies with concurrent parvovirus, the decision to add antibiotics to parvovirus treatment requires careful assessment of the bacterial co-infection’s role in the clinical picture versus the known risks of antibiotic treatment in the context of severe parvoviral enteritis
Adult Dogs (1 to 8 Years)
- Healthy adult dogs that are asymptomatic Campylobacter shedders represent the most common situation encountered in clinical practice; a positive Campylobacter test result on a fecal panel submitted for routine wellness or diarrhea workup in a dog with normal or mildly abnormal stool is a common finding, particularly in raw-fed dogs; the critical clinical question is whether the positive result explains the dog’s clinical signs or represents incidental shedding in a dog whose diarrhea has another cause; treating every positive test with antibiotics in an asymptomatic dog is inappropriate, contributes to resistance selection, and does not reliably eliminate shedding
- Adult dogs with clinical campylobacteriosis (mucoid bloody diarrhea, tenesmus, vomiting) typically respond well to a brief course of azithromycin plus supportive care; resolution of clinical signs within 5 to 7 days is the expected outcome in immunocompetent adult dogs without significant concurrent disease; if clinical signs do not improve within 3 to 4 days of treatment, reconsider the diagnosis, reassess for concurrent pathogens, and consider culture with susceptibility testing to exclude macrolide-resistant strains; macrolide resistance in C. jejuni is uncommon compared to fluoroquinolone resistance but does occur, particularly in dogs exposed to macrolide-treated livestock
- Adult dogs on raw meat diets who have multiple Campylobacter-positive tests over time, or who have recurrent bouts of clinical diarrhea attributed to Campylobacter, present an opportunity for dietary counseling; the most effective single intervention to reduce ongoing colonization and clinical disease risk is transitioning from a raw meat diet to a commercially processed food; the counseling conversation should acknowledge owner attachment to the raw diet philosophy while clearly explaining the documented colonization risk and the zoonotic implications, particularly relevant if the household includes children, elderly family members, or immunocompromised individuals
Senior Dogs (9 Years and Older)
- Senior dogs with Campylobacter infection may experience more prolonged or severe clinical signs than healthy young adults due to age-associated declines in intestinal immune function and mucosal barrier integrity, concurrent conditions (chronic kidney disease, liver disease, Cushing’s disease, hypothyroidism, inflammatory bowel disease) that affect intestinal health or immune competence, and concurrent medications (corticosteroids, cyclosporine, chemotherapy agents) that suppress immune function; a senior dog on immunosuppressive therapy for immune-mediated disease who develops bloody diarrhea with a positive Campylobacter fecal test is a clinical scenario where antibiotic treatment is clearly warranted, even at lower thresholds than in a healthy young adult
- In senior dogs, differentiating campylobacteriosis from other causes of large bowel diarrhea is important before attributing clinical signs to Campylobacter; inflammatory bowel disease (IBD), protein-losing enteropathy, colonic neoplasia (adenocarcinoma), and trichuriasis (whipworm infection) all produce similar signs and are more common in older dogs; a positive Campylobacter PCR does not exclude these differential diagnoses; if the dog does not respond to appropriate antibiotic treatment within 7 to 10 days, more extensive diagnostic workup (colonoscopy with biopsy, abdominal ultrasound, protein electrophoresis) is indicated
- Senior dogs with confirmed clinical campylobacteriosis and no complicating factors generally respond to azithromycin as well as younger adults; however, renal function should be considered if dehydration is significant, and fluid therapy dosing should account for concurrent heart or kidney disease; avoid fluoroquinolones empirically in senior dogs with any history of renal insufficiency, as fluoroquinolones can be nephrotoxic and worsen pre-existing renal disease; erythromycin’s prokinetic effects via motilin receptor agonism may actually exacerbate diarrhea in some dogs and should be used cautiously in seniors with severe diarrhea
Myths and Facts About Campylobacteriosis in Dogs
If the standard fecal culture at my vet came back negative for bacteria, my dog definitely does not have Campylobacter.
Standard fecal cultures at many veterinary clinics are not set up to detect Campylobacter; the organism requires specialized selective media (Campy-BAP or CCDA agar), a microaerophilic atmosphere (not standard aerobic culture), and incubation at 42 degrees Celsius rather than 37 degrees Celsius. A negative “standard fecal culture” does not rule out Campylobacter. Request specifically a Campylobacter culture or, better, submit a fecal PCR panel that includes Campylobacter for reliable results.
Once my dog finishes the antibiotic course and the diarrhea stops, they are no longer contagious and it is safe for them to be around other dogs and family members.
Antibiotic treatment does not reliably eliminate Campylobacter shedding in dogs; studies show that dogs continue to shed the organism in their feces for weeks after both clinical resolution and antibiotic treatment. A clinically recovered dog may still shed viable C. jejuni for 2 to 4 weeks or longer. Handwashing precautions and careful fecal disposal should continue for at least 4 weeks after clinical recovery, particularly in households with immunocompromised members.
I found Campylobacter on my dog’s routine wellness fecal panel but my dog has no diarrhea, so I should treat immediately to prevent it from getting sick or spreading to my family.
Asymptomatic Campylobacter shedding is common in dogs (especially raw-fed dogs and recently acquired puppies) and treating every positive test with antibiotics is not recommended by infectious disease guidelines; antibiotic treatment does not reliably eliminate shedding and contributes to resistance selection. The appropriate response is strict handwashing hygiene, switching from raw food if applicable, and monitoring for clinical signs. Antibiotic treatment is warranted when clinical signs develop, not based solely on a positive test result in a healthy dog without diarrhea.
Red Flags: Signs Requiring Prompt Veterinary Evaluation
- Puppy under 12 weeks with bloody diarrhea and vomiting lasting more than 24 hours without improvement: puppies dehydrate rapidly and can develop life-threatening hypoglycemia and circulatory collapse; this is an urgent situation requiring same-day evaluation; concurrent parvovirus must be ruled out because the clinical presentation overlaps and parvovirus requires intensive hospitalization
- Diarrhea with large amounts of frank blood (more than a blood-stained stool surface, with actual blood passage or clots in the stool): while Campylobacter causes bloody diarrhea, large-volume hemorrhage may indicate a more serious concurrent condition such as hemorrhagic gastroenteritis, intussusception, parvovirus, or intestinal neoplasia
- Failure to improve after 3 to 4 days of appropriate azithromycin treatment: reconsider the diagnosis; obtain culture and antimicrobial susceptibility testing to identify macrolide-resistant strains; reassess for concurrent pathogens that are not responding to the current regimen; consider colonoscopy if adult or senior dog with atypical presentation
- Diarrhea with signs of systemic illness (high fever above 40 degrees Celsius, profound lethargy, collapse, pale mucous membranes, rapid heart rate): systemic signs suggest possible bacteremia, extraintestinal infection, or a more serious concurrent condition; hospitalization and IV antibiotics may be needed
- Dog on immunosuppressive medication (corticosteroids, cyclosporine, azathioprine, chemotherapy) who develops bloody diarrhea: immunosuppressed dogs face higher risk of severe or extraintestinal campylobacteriosis; prompt treatment is warranted at lower thresholds than in healthy dogs; notify the prescribing veterinarian before adjusting immunosuppressive drugs
- Human household member develops diarrhea at the same time as or shortly after the dog: potential zoonotic transmission has occurred; the household member should contact their primary care provider and mention the dog’s diagnosis; C. jejuni infection in immunocompromised humans can be severe and require systemic antibiotic treatment
US Cost Overview for Campylobacteriosis
| Service | Typical US Cost |
|---|---|
| Veterinary examination | $60 to $150 |
| Fecal PCR multiplex panel (includes Campylobacter, Giardia, Salmonella, Clostridium, parvovirus) | $80 to $180 |
| Campylobacter-specific fecal culture | $40 to $90 |
| Antimicrobial susceptibility testing (on isolate) | $30 to $60 |
| Fecal flotation (for parasite co-infection) | $25 to $50 |
| Azithromycin (3 to 5-day course) | $15 to $40 (generic available) |
| IV fluids and hospitalization per day (puppies with severe dehydration) | $300 to $700 |
| Total for mild outpatient case | $200 to $500 |
| Total for hospitalized puppy (1 to 2 days) | $600 to $1,500 |
Frequently Asked Questions About Campylobacteriosis in Dogs
What causes campylobacteriosis in dogs?
Campylobacteriosis is caused by Campylobacter bacteria, primarily Campylobacter jejuni in dogs; Campylobacter coli and C. upsaliensis are also found but less commonly. C. jejuni is a curved gram-negative rod requiring microaerophilic culture conditions at 42 degrees Celsius. Dogs acquire the infection through ingestion of contaminated raw meat (especially poultry), contaminated water, fecal contact with infected animals, or from their dam at birth.
Can my dog give me Campylobacter?
Yes. Campylobacter jejuni is zoonotic and can be transmitted from dogs to humans through fecal-oral contact. Dogs with clinical campylobacteriosis, and even asymptomatic shedders, pass the organism in feces. Handwashing after handling dogs or their feces is the most effective preventive measure. Risk is highest in households with young children, elderly individuals, pregnant people, and immunocompromised individuals.
Why won’t my vet’s standard fecal culture detect Campylobacter?
Standard fecal cultures use aerobic conditions at 37 degrees Celsius, which will NOT grow Campylobacter. C. jejuni requires a microaerophilic atmosphere (5 percent oxygen, 10 percent CO2), selective media such as Campy-BAP or CCDA agar, and incubation at 42 degrees Celsius. Always specifically request “Campylobacter culture” or submit a fecal PCR panel, which is more sensitive and does not require viable organisms.
What antibiotic treats Campylobacter in dogs?
Azithromycin 5 mg/kg orally once daily for 3 to 5 days is the first-line antibiotic. Macrolides are preferred because fluoroquinolone resistance (to enrofloxacin and ciprofloxacin) has increased substantially due to fluoroquinolone use in commercial poultry production. Enrofloxacin should only be used when susceptibility is confirmed on culture and sensitivity testing. Antibiotic treatment shortens the clinical illness but does not reliably eliminate fecal shedding.
Does raw feeding cause Campylobacter in dogs?
Raw feeding is the most consistently identified risk factor for Campylobacter colonization. Studies report significantly higher shedding prevalence in raw-fed dogs compared to kibble-fed dogs. Commercial raw diets (frozen, freeze-dried) based on poultry are high-risk because C. jejuni colonizes 50 to 90 percent of commercial broiler chickens. Switching to commercially processed food reduces colonization risk. Owners who continue raw feeding should practice strict hygiene around food preparation and waste disposal.
My dog’s Campylobacter test is positive but the dog has no diarrhea. What should I do?
Asymptomatic shedding is common, particularly in raw-fed dogs and shelter dogs. Antibiotic treatment of asymptomatic carriers is generally not recommended because it does not reliably eliminate shedding and contributes to antimicrobial resistance. The appropriate response is strict handwashing, switching from raw food if applicable, and monitoring for clinical signs. Treat only when clinical signs develop, or in households with immunocompromised members where the risk threshold is lower.
How long is a dog with Campylobacter contagious?
Dogs may shed Campylobacter in their feces for 2 to 4 weeks or longer after clinical recovery, even after antibiotic treatment. Treatment shortens illness but does not reliably eliminate shedding. Maintain handwashing precautions and prompt fecal disposal for at least 4 weeks after the diarrhea resolves, particularly in households with immunocompromised or elderly members or young children.
For more guides on keeping your dog healthy, browse all our Dog Health articles.
Explore Dog Health Articles